Clairo

Senior Clinical Data Programmer

United Kingdom

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, Healthcare, Digital HealthIndustries

Requirements

Candidates must possess a BS/BA in Life Sciences, Computer Science, or a related field, along with a SAS Advanced Certification. A minimum of 10 years of SAS programming experience in the pharma or CRO industry is required, including SAS/Base, SAS/Macro, and SAS/SQL. Additionally, 1+ years of experience in database design and data structures, 5+ years in the pharmaceutical or healthcare industry, and familiarity with CDISC SDTM and Define standards are necessary. Strong organizational, analytical, communication, and time management skills, attention to detail, proficiency in Windows and Microsoft Office, and fluency in English are essential. Experience with other programming languages and working with large, complex patient data sets are considered a plus.

Responsibilities

The Senior Clinical Data Programmer will develop and test SAS code for data file creation, review data specifications, and collaborate with Data Managers to finalize them. Responsibilities include attending client meetings, validating encoding programs, performing ad-hoc programming for quality control and data resolution, and supporting programming for data review. The role involves gaining exposure across modalities, becoming a Subject Matter Expert (SME) in key offerings, and contributing to functional and technical specifications. Additionally, the programmer will participate in audits, represent Clinical Data Programming in NPI processes, identify and implement process improvements, contribute to best practices, act as a CDP SME in cross-functional meetings, mentor new team members, support onboarding, develop SOPs, and complete administrative tasks.

Skills

SAS
SAS/Base
SAS/Macro
SAS/SQL
Database Design
Data Structures
Clinical Data Programming
Data Management
Quality Control
Process Improvement
SOP Development

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI